193 related articles for article (PubMed ID: 32898469)
1. SARS-CoV-2 envelope protein topology in eukaryotic membranes.
Duart G; García-Murria MJ; Grau B; Acosta-Cáceres JM; Martínez-Gil L; Mingarro I
Open Biol; 2020 Sep; 10(9):200209. PubMed ID: 32898469
[TBL] [Abstract][Full Text] [Related]
2. Host-membrane interacting interface of the SARS coronavirus envelope protein: Immense functional potential of C-terminal domain.
Mukherjee S; Bhattacharyya D; Bhunia A
Biophys Chem; 2020 Nov; 266():106452. PubMed ID: 32818817
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Bhowmik D; Nandi R; Jagadeesan R; Kumar N; Prakash A; Kumar D
Infect Genet Evol; 2020 Oct; 84():104451. PubMed ID: 32640381
[TBL] [Abstract][Full Text] [Related]
4. Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
Bianchi M; Benvenuto D; Giovanetti M; Angeletti S; Ciccozzi M; Pascarella S
Biomed Res Int; 2020; 2020():4389089. PubMed ID: 32596311
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 strategically mimics proteolytic activation of human ENaC.
Anand P; Puranik A; Aravamudan M; Venkatakrishnan AJ; Soundararajan V
Elife; 2020 May; 9():. PubMed ID: 32452762
[TBL] [Abstract][Full Text] [Related]
6. Limits of Detection of 6 Approved RT-PCR Kits for the Novel SARS-Coronavirus-2 (SARS-CoV-2).
Wang X; Yao H; Xu X; Zhang P; Zhang M; Shao J; Xiao Y; Wang H
Clin Chem; 2020 Jul; 66(7):977-979. PubMed ID: 32282874
[No Abstract] [Full Text] [Related]
7. Comparing the binding properties of peptides mimicking the Envelope protein of SARS-CoV and SARS-CoV-2 to the PDZ domain of the tight junction-associated PALS1 protein.
Toto A; Ma S; Malagrinò F; Visconti L; Pagano L; Stromgaard K; Gianni S
Protein Sci; 2020 Oct; 29(10):2038-2042. PubMed ID: 32822073
[TBL] [Abstract][Full Text] [Related]
8. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
9. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
10. Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs.
Park SY; Yun SG; Shin JW; Lee BY; Son HJ; Lee S; Lee E; Kim TH
Korean J Intern Med; 2020 Jul; 35(4):793-796. PubMed ID: 32549526
[TBL] [Abstract][Full Text] [Related]
11. International Expansion of a Novel SARS-CoV-2 Mutant.
Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121
[No Abstract] [Full Text] [Related]
12. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
13. Immunoinformatic analysis of the SARS-CoV-2 envelope protein as a strategy to assess cross-protection against COVID-19.
Tilocca B; Soggiu A; Sanguinetti M; Babini G; De Maio F; Britti D; Zecconi A; Bonizzi L; Urbani A; Roncada P
Microbes Infect; 2020; 22(4-5):182-187. PubMed ID: 32446902
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
Kim CH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
[TBL] [Abstract][Full Text] [Related]
15. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.
Rattanapisit K; Shanmugaraj B; Manopwisedjaroen S; Purwono PB; Siriwattananon K; Khorattanakulchai N; Hanittinan O; Boonyayothin W; Thitithanyanont A; Smith DR; Phoolcharoen W
Sci Rep; 2020 Oct; 10(1):17698. PubMed ID: 33077899
[TBL] [Abstract][Full Text] [Related]
16. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
17. Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies.
Sarkar M; Saha S
PLoS One; 2020; 15(8):e0237300. PubMed ID: 32785274
[TBL] [Abstract][Full Text] [Related]
18. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
Vishnubalaji R; Shaath H; Alajez NM
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
[TBL] [Abstract][Full Text] [Related]
19. Preparedness and Rapid Implementation of External Quality Assessment Helped Quickly Increase COVID-19 Testing Capacity in the Republic of Korea.
Sung H; Yoo CK; Han MG; Lee SW; Lee H; Chun S; Lee WG; Min WK
Clin Chem; 2020 Jul; 66(7):979-981. PubMed ID: 32321159
[No Abstract] [Full Text] [Related]
20. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
